Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,569 | 13,949 | 10,954 | 12,113 | 12,781 |
| Marketable Securities | 6,827 | 6,415 | 6,448 | 3,828 | 4,283 |
| Receivables | 6,335 | 4,924 | 5,479 | 2,994 | 4,411 |
| Inventories | 5,899 | 4,861 | 5,277 | 5,328 | 5,660 |
| Other current assets | 0 | 0 | 0 | 6 | 22 |
| TOTAL | $35,969 | $30,592 | $28,642 | $24,471 | $27,550 |
| Non-Current Assets | |||||
| PPE Net | 1,040 | 1,105 | 1,154 | 1,201 | 1,255 |
| Investments And Advances | 5,401 | 6,497 | 7,497 | 10,104 | 10,497 |
| Intangibles | 4,949 | 4,846 | 4,966 | 5,042 | 5,711 |
| Other Non-Current Assets | 426 | 455 | 503 | 542 | 458 |
| TOTAL | $11,816 | $12,903 | $14,120 | $16,888 | $17,921 |
| Total Assets | $47,785 | $43,495 | $42,762 | $41,359 | $45,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,407 | 3,806 | 4,756 | 3,999 | 6,251 |
| Other current liabilities | 16 | 13 | 9 | N/A | N/A |
| TOTAL | $7,107 | $5,042 | $5,847 | $5,405 | $7,034 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 162 | 824 | 123 | 813 | 342 |
| TOTAL | $776 | $852 | $904 | $951 | $1,090 |
| Total Liabilities | $7,883 | $5,895 | $6,750 | $6,356 | $8,124 |
| Shareholders' Equity | |||||
| Common Shares | 5,240 | 5,174 | 5,139 | 5,306 | 5,136 |
| Retained earnings | 32,823 | 30,714 | 29,270 | 27,729 | 30,261 |
| Other shareholders' equity | -172 | -179 | -172 | -172 | -203 |
| TOTAL | $39,903 | $37,601 | $36,012 | $35,003 | $37,346 |
| Total Liabilities And Equity | $47,785 | $43,495 | $42,762 | $41,359 | $45,471 |